Results 21 to 30 of about 273,783 (254)
New diagnostics for tuberculosis: fulfilling patient needs first
Journal of the International AIDS Society, 2010 Background An effective tuberculosis (TB) control programme requires early diagnosis and immediate initiation of treatment. Any delays in diagnosing TB not only impair a patient's prognosis, but also increase the risks of transmitting the disease within ...
Jean‐François Lemaire +1 more
doaj +1 more source
Impact of a COVID-19 National Lockdown on Integrated Care for Hypertension and HIV
Global Heart, 2021 Research Letter Introduction: Measures to limit the spread of COVID-19, such as movement restrictions, are anticipated to worsen outcomes for chronic conditions such as hypertension (HTN), in part due to decreased access to medicines. However, the actual
Jeremy I. Schwartz +6 more
doaj +1 more source
BMC Public Health, 2019 Background As the data on the association of mental disorders and chronic physical diseases in developing and emerging countries is heterogeneous, this study aims to produce the first meta-analysis of these comorbidities.
Labanté Outcha Daré +6 more
doaj +1 more source
Public Health Ethics, 2008 I would pay three million to go into space, says the banker to his attorney. — I wouldn't go if you paid me, the latter laughs, for me the French Riviera is quite exciting enough.Ah, I would pay a million for an extra year of life, the elderly tourist effusively tells his lover. — We have never had even a hundred dollars, the Cambodian teenager replies,
openaire +2 more sources
Open access and medicinal chemistry [PDF]
Chemistry Central Journal, 2007 Chemistry Central is a new open access website for chemists publishing peer-reviewed research in chemistry from a range of open access journals. A new addition, Chemistry Central Journal, will cover all of chemistry and will be broken down into discipline-specific sections, and Im delighted that Medicinal Chemistry will be a key discipline in this new ...
openaire +3 more sources
What's in a Word? Falsified/Counterfeit/Fake Medicines - The Definitions Debate
Medicine Access @ Point of Care, 2017 There is a rising tide of criminal activity to manufacture and distribute falsified, counterfeit, or fake medicines. The exact size of this problem is unknown but estimates vary from US$75 billion to US$200 billion per year, and evidence clearly ...
Mike Isles
doaj +1 more source
BMC Infectious DiseasesBackground Outbreaks of high-threat zoonotic diseases like Ebola virus disease (EVD) occur more frequently, causing severe health and socioeconomic impacts.
Charlot Diepvens +5 more
doaj +1 more source
Access to Medicines and the Rhetoric of Responsibility
Ethics & International Affairs, 2002 There is no cure or vaccine for HIV/AIDS. The only life-prolonging treatment available is antiretroviral (ARV) therapy. WHO estimates, however, that less than 5 percent of those who require treatment in developing countries currently enjoy access to these medicines.
Barry, Christian, Raworth, Kate
openaire +2 more sources
Promising Trends in Access to Medicines [PDF]
Global Policy, 2012 AbstractIt is a vast understatement to say that the problem of access to medicines in developing countries is complex. Access is limited by a range of factors including inability to pay, a lack of infrastructure, and corruption in some countries. Surrounding and exacerbating these structural and technological problems is the layer of legal rights ...
Morin, Jean-Frédéric, Gold, Richard E.
openaire +3 more sources
Missing data on accessibility of children’s medicines
Bulletin of the World Health Organization, 2022 Child-appropriate medicines are essential for the safe and effective treatment of children, yet we have observed a large gap in the data required to adequately monitor access to these medicines. We have examined data on the availability and pricing of child-appropriate medicines across 50 surveys. Child-appropriate medicines for nine out of 12 priority
Joosse, Iris R +4 more
openaire +4 more sources